Skip to main content
letter
. 2021 Mar 17;5(6):1729–1732. doi: 10.1182/bloodadvances.2020003797

Figure 2.

Figure 2.

POD24, OS, and survival after progression according to treatment arm. (A) POD24 by treatment arm. (B) OS by treatment arm, measured from registration. (C) OS according to POD24 status for the whole cohort. (D) OS according to POD24 status by treatment arm.